Literature DB >> 23760081

A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.

Yoon Jun Kim, Hwi Young Kim, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Hyo-Suk Lee, Chung Yong Kim, Jae Youn Cheong, Sung Won Cho, Neung Hwa Park, Byung Lae Park, Seok Namgoong, Lyoung Hyo Kim, Hyun Sub Cheong, Hyoung Doo Shin.   

Abstract

UNLABELLED: Hepatitis B virus (HBV) infection is the predominant risk factor for chronic hepatitis B (CHB), liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Recently, several genome-wide association studies (GWASs) of CHB identified human leukocyte antigen (HLA) loci, including HLA-DP and HLA-DQ in Asian populations, as being associated with the risk of CHB. To confirm and identify the host genetic factors related to CHB infection, we performed another GWAS using a higher-density chip in Korean CHB carriers. We analyzed 1400 samples from Korean population (400 CHB cases and 1000 population controls) using a higher-density GWAS chip [1 140 419 single nucleotide polymorphisms (SNPs)]. In subsequent replication analysis, we further analyzed in an independent study of a Korean CHB cohort consisting of 2909 Korean samples (971 cases and 1938 controls). Logistic regression methods were used for statistical analysis adjusting for age and sex as covariates. This study identified two new risk-associated loci for CHB on the HLA region of chromosome 6, e.g. rs652888 on euchromatic histone-lysine-methyltransferase 2 (EHMT2, P = 7.07 × 10(-13)) and rs1419881 on transcription factor 19 (TCF19, P = 1.26 × 10(-18)). Conditional analysis with nearby HLA CHB loci that were previously known, confirmed the independent genetic effects of these two loci on CHB.
CONCLUSION: The GWAS and the subsequent validation study identified new variants associated with the risk of CHB. These findings may advance the understanding of genetic susceptibility to CHB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760081     DOI: 10.1093/hmg/ddt266

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.

Authors:  Pengyuan Yang; Geoffrey J Markowitz; Xiao-Fan Wang
Journal:  Natl Sci Rev       Date:  2014-07-14       Impact factor: 17.275

2.  Liver-specific knockout of histone methyltransferase G9a impairs liver maturation and dysregulates inflammatory, cytoprotective, and drug-processing genes.

Authors:  Hong Lu; Xiaohong Lei; Qinghao Zhang
Journal:  Xenobiotica       Date:  2018-07-23       Impact factor: 1.908

3.  Linkage Analysis of Urine Arsenic Species Patterns in the Strong Heart Family Study.

Authors:  Matthew O Gribble; Venkata Saroja Voruganti; Shelley A Cole; Karin Haack; Poojitha Balakrishnan; Sandra L Laston; Maria Tellez-Plaza; Kevin A Francesconi; Walter Goessler; Jason G Umans; Duncan C Thomas; Frank Gilliland; Kari E North; Nora Franceschini; Ana Navas-Acien
Journal:  Toxicol Sci       Date:  2015-07-23       Impact factor: 4.849

4.  Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai Population.

Authors:  Saeideh Ashouri; Seik-Soon Khor; Yuki Hitomi; Hiromi Sawai; Nao Nishida; Masaya Sugiyama; Yosuke Kawai; Nawarat Posuwan; Pisit Tangkijvanich; Piyawat Komolmit; Makoto Tsuiji; Vorasuk Shotelersuk; Yong Poovorawan; Masashi Mizokami; Katsushi Tokunaga
Journal:  Front Genet       Date:  2022-06-13       Impact factor: 4.772

5.  Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population.

Authors:  Behnaz Riazalhosseini; Zahurin Mohamed; Yamunah Devi Apalasamy; Noor Shafila Shafie; Rosmawati Mohamed
Journal:  Biomed Rep       Date:  2018-07-09

Review 6.  Beyond Metabolism: Role of the Immune System in Hepatic Toxicity.

Authors:  Kenneth L Hastings; Martin D Green; Bin Gao; Patricia E Ganey; Robert A Roth; Gary R Burleson
Journal:  Int J Toxicol       Date:  2020 Mar/Apr       Impact factor: 2.032

7.  Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma.

Authors:  Cong Li; Xinyu Bi; Ying Huang; Jianjun Zhao; Zhiyu Li; Jianguo Zhou; Meng Zhang; Zhen Huang; Hong Zhao; Jianqiang Cai
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

8.  Genome-wide copy number variation analysis of hepatitis B infection in a Japanese population.

Authors:  Masataka Kikuchi; Kaori Kobayashi; Nao Nishida; Hiromi Sawai; Masaya Sugiyama; Masashi Mizokami; Katsushi Tokunaga; Akihiro Nakaya
Journal:  Hum Genome Var       Date:  2021-06-08

9.  Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in thai population.

Authors:  Nawarat Posuwan; Sunchai Payungporn; Pisit Tangkijvanich; Shintaro Ogawa; Shuko Murakami; Sayuki Iijima; Kentaro Matsuura; Noboru Shinkai; Tsunamasa Watanabe; Yong Poovorawan; Yasuhito Tanaka
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

Review 10.  Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers.

Authors:  Wen-Hui Su; Allan Hildesheim; Yu-Sun Chang
Journal:  Front Oncol       Date:  2013-12-09       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.